Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloid Beta-Protein”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Testing effectiveness (Phase 2)Looking for participantsNCT06659549
What this trial is testing

Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

Who this might be right for
Geographic Atrophy of the Macula
Galimedix Therapeutics Inc 110
Not applicableStudy completedNCT06604390
What this trial is testing

The EFFECTS of GAMBIR CATECHIN (UNCARIA GAMBIR ROXB) SUPPLEMENTATION on COGNITIVE FUNCTION, EXPRESSION of APP, MAPT, BDNF, IL-10, TGF-Β GENES, and PLASMA MDA LEVELS in the ELDERLY.

Who this might be right for
Elderly Individuals Aged 60 Years or OlderMild Cognitive Impairment (MCI)
Rahmi Novita Yusuf 64
Testing effectiveness (Phase 2)Study completedNCT03417986
What this trial is testing

Clinical Trial to Explore the the Amyloid Beta Draining Effect of Thiethylperazine (TEP) in Subjects With Newly Diagnosed Early-to-mild Dementia Due to Alzheimer's Disease (AD) in Comparison to Healthy Volunteers

Who this might be right for
Alzheimer Disease
Immungenetics AG 20
Not applicableStudy completedNCT01857830
What this trial is testing

The Relaxation vs. Retreat Study

Who this might be right for
StressAgeingWellbeing
University of California, San Francisco 96
Not applicableStudy completedNCT02021682
What this trial is testing

CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Washington University School of Medicine 58
Large-scale testing (Phase 3)Active Not RecruitingNCT05463731
What this trial is testing

Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 1,667
Testing effectiveness (Phase 2)Study completedNCT00750282
What this trial is testing

Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers

Who this might be right for
Alzheimer DiseaseAmyloid Beta-Protein
Life Molecular Imaging SA 422
Early research (Phase 1)Ended earlyNCT00870519
What this trial is testing

Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Who this might be right for
Alzheimer's Disease
Institute for Neurodegenerative Disorders 2
Not applicableLooking for participantsNCT07402356
What this trial is testing

VR Pupillometry in Cognitive Impairment

Who this might be right for
Alzheimer s DiseaseMajor Depressive Disorder (MDD)Mild Cognitive Impairment+1 more
Max-Planck-Institute of Psychiatry 140
Early research (Phase 1)Study completedNCT00214851
What this trial is testing

The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria

Who this might be right for
Familial Cold Urticaria
Nova Scotia Health Authority 8
Post-approval studies (Phase 4)Study completedNCT02161458
What this trial is testing

Escitalopram Effects on CSF Amyloid Beta

Who this might be right for
Amyloid Beta Protein
University of Pennsylvania 98
Not applicableUnknownNCT01128725
What this trial is testing

Truncated and Extended Forms of Amyloid Beta Peptides in Alzheimer's Disease: Genesis, Toxicity and Identification as Biological Markers

Who this might be right for
Alzheimer Disease
Centre Hospitalier Universitaire de Nice 100
Early research (Phase 1)Study completedNCT03522129
What this trial is testing

Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Cognition Therapeutics 3
Not applicableStudy completedNCT02129452
What this trial is testing

Olfactory Neuroepithelial Tissue of Alzheimer Disease

Who this might be right for
Alzheimer Disease
Seoul National University Hospital 40
Testing effectiveness (Phase 2)UnknownNCT04174287
What this trial is testing

Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Chang Gung Memorial Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT04629547
What this trial is testing

Sleep Trial to Prevent Alzheimer's Disease

Who this might be right for
SleepAlzheimer Disease
Washington University School of Medicine 200
Not applicableStudy completedNCT01754168
What this trial is testing

Amyloid Beta and Cognition in Parkinson Disease

Who this might be right for
Parkinson DiseaseNeurological Disorders
University of Michigan 44
Not applicableStudy completedNCT03077620
What this trial is testing

Sleep Quality and Amyloid-Beta Kinetics

Who this might be right for
Amyloid-beta
Washington University School of Medicine 48
Early research (Phase 1)Ended earlyNCT00605059
What this trial is testing

Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 3
Not applicableStudy completedNCT07294586
What this trial is testing

Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementiaNeurodegenerative Disorders+5 more
Amoneta Diagnostics SAS 200
Load More Results